Zacks.com features top research reports on Microsoft Corp., Amazon.com, Inc., and Eli Lilly and Co. Microsoft’s strong fiscal first-quarter results show robust fundamentals, with net sales expected to grow by 15.1% in fiscal 2026. Amazon’s third-quarter results demonstrated pricing power and strong Prime engagement, while Eli Lilly’s Q3 earnings and sales beat estimates, with key top-line drivers like GLP-1 drugs contributing to growth. A semiconductor stock is identified as a valuable investment opportunity in the growing data market.

Read more at Nasdaq: The Zacks Analyst Blog Highlights Microsoft, Amazon.com and Eli Lilly